secwatch.observer — SEC 8-K summary
======================================

Issuer:     Larimar Therapeutics, Inc. (LRMR)
CIK:        0001374690
Form:       8-K
Filed at:   2025-05-05T23:59:59+00:00
Accession:  0000950170-25-063125
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Larimar posts updated corporate presentation; no material new data
------------------------------------------------------------------

- Updated slide deck dated May 5, 2025 posted on company website.
- Presentation intended for use in meetings with investors, analysts, and other parties.
- Filing does not disclose any new financial, clinical, or operational information.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1374690/000095017025063125/0000950170-25-063125-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1374690/000095017025063125/lrmr-20250505.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-063125

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer